David Snow — SPARQNOW

At-a-Glance

Named #27 on the Harvard Business Review's “Best Performing CEOs in the World" in 2010.
Serves as Chairman and CEO of Cedar Gate Technologies, a healthcare predictive and prescriptive analytics company, which he founded in 2014.
Founded Americhoice, a drug development company, which he sold to UnitedHealth Group for $570 million.
As CEO of Medco Health Solutions, led the company into a public offering on the New York Stock Exchange in August 2003, increased revenue from $35 billion to $72 billion, and quadrupled market capitalization.
Serves on the board of directors for Pitney Bowes, Teladoc, and CareCentrix.
Holds a master's degree in health care administration from Duke University's Fuqua School of Business (1978).

Biography

David B. Snow Jr. is a distinguished American business executive, currently serving as the Chairman and Chief Executive Officer of Cedar Gate Technologies, a healthcare predictive and prescriptive analytics company he founded in February 2014. He invested $20 million of his personal funds into the company and raised an additional $200 million from GTCR.

Prior to Cedar Gate Technologies, Snow held significant leadership roles in the healthcare industry.